Mirati Therapeutics, Inc. is a clinical stage biopharmaceutical company. The Company is focused on developing a pipeline of targeted oncology products.
In order to optimize our website for you and to be able to continuously improve it, we use cookies. By continuing to use the website, you agree to the use of cookies. Further information on cookies can be found in our Privacy Policy.
